Metagenomi, Inc.
MGX
$1.67
$0.159.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -22.46% | -6.87% | 76.48% | 28.90% | 121.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -22.46% | -6.87% | 76.48% | 28.90% | 121.61% |
| Cost of Revenue | -6.43% | -2.16% | 24.86% | 56.18% | 64.41% |
| Gross Profit | -9.66% | -1.85% | 26.73% | -76.76% | -30.59% |
| SG&A Expenses | -9.78% | -3.53% | 29.19% | 35.38% | 24.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.23% | -2.48% | 25.84% | 51.12% | 52.59% |
| Operating Income | -2.11% | 0.05% | 6.12% | -61.85% | -28.10% |
| Income Before Tax | -48.52% | -12.17% | -16.45% | -80.45% | -20.22% |
| Income Tax Expenses | -144.31% | -274.63% | -215.86% | -- | 222.22% |
| Earnings from Continuing Operations | -21.27% | 5.28% | 17.44% | -55.88% | -31.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.27% | 5.28% | 17.44% | -55.88% | -31.91% |
| EBIT | -2.11% | 0.05% | 6.12% | -61.85% | -28.10% |
| EBITDA | -0.88% | 1.05% | 8.25% | -62.36% | -26.24% |
| EPS Basic | 88.93% | 91.23% | 80.86% | 74.89% | -31.91% |
| Normalized Basic EPS | 90.37% | 90.64% | 78.54% | 70.93% | -20.23% |
| EPS Diluted | 88.93% | 91.23% | 80.86% | 74.89% | -31.91% |
| Normalized Diluted EPS | 90.37% | 90.64% | 78.54% | 70.93% | -20.23% |
| Average Basic Shares Outstanding | 995.76% | 979.90% | 331.37% | 520.86% | 0.00% |
| Average Diluted Shares Outstanding | 995.76% | 979.90% | 331.37% | 520.86% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |